Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque
2020 · Circulation · 507 citations
https://doi.org/10.1161/circulationaha.120.049981
L
Leyre Zubiri
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
143
Papers
6.4K
Citations
37
h-index
60
i10-index
Leyre Zubiri is an academic researcher. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & COVID-19 and healthcare impacts & Colorectal Cancer Treatments and Studies. The author has an h-index of 37, co-authored 122 publications.
ORCID: 0000-0003-4226-7443Papers by this author
worksThe Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors
2019 · Clinical Journal of the American Society of Nephrology · 293 citations
https://doi.org/10.2215/cjn.00990119
Clinical and laboratory features of autoimmune hemolytic anemia associated with immune checkpoint inhibitors
2019 · American Journal of Hematology · 76 citations
https://doi.org/10.1002/ajh.25448
Pericardial disease in patients treated with immune checkpoint inhibitors
2021 · Journal for ImmunoTherapy of Cancer · 76 citations
https://doi.org/10.1136/jitc-2021-002771
Incidence and Clinical Features of Immune-Related Acute Kidney Injury in Patients Receiving Programmed Cell Death Ligand-1 Inhibitors
2020 · Kidney International Reports · 74 citations
https://doi.org/10.1016/j.ekir.2020.07.011
Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: A multi-institutional cohort study
2023 · Journal of the American Academy of Dermatology · 68 citations
https://doi.org/10.1016/j.jaad.2022.12.048
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat